{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:05:33Z","timestamp":1772805933141,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":6351,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1194\/jlr.m200439-jlr200","type":"journal-article","created":{"date-parts":[[2003,3,31]],"date-time":"2003-03-31T19:11:36Z","timestamp":1049137896000},"page":"800-806","source":"Crossref","is-referenced-by-count":67,"title":["Impact of simvastatin, niacin, and\/or antioxidants on cholesterol metabolism in CAD patients with low HDL"],"prefix":"10.1016","volume":"44","author":[{"given":"Nirupa R.","family":"Matthan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Giovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.Greg","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice H.","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M200439-JLR200_bib1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","article-title":"Multiple Risk Factor Intervention Trial: risk factor changes and mortality results","volume":"248","year":"1982","journal-title":"JAMA."},{"key":"10.1194\/jlr.M200439-JLR200_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial Result 1: Reduction in incidence of coronary heart disease","volume":"251","year":"1984","journal-title":"JAMA."},{"key":"10.1194\/jlr.M200439-JLR200_bib3","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1001\/jama.1987.03390160062027","article-title":"Cholesterol and mortality: 30 years of follow-up from the Framingham study","volume":"257","author":"Anderson","year":"1987","journal-title":"JAMA."},{"key":"10.1194\/jlr.M200439-JLR200_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation."},{"key":"10.1194\/jlr.M200439-JLR200_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.ATV.17.1.107","article-title":"Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men","volume":"17","author":"Goldbourt","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M200439-JLR200_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00041433-200012000-00010","article-title":"Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?","volume":"11","author":"von Eckardstein","year":"2000","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M200439-JLR200_bib7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA."},{"key":"10.1194\/jlr.M200439-JLR200_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib9","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet."},{"key":"10.1194\/jlr.M200439-JLR200_bib10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"New Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet."},{"key":"10.1194\/jlr.M200439-JLR200_bib13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet."},{"key":"10.1194\/jlr.M200439-JLR200_bib14","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib15","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM199708073370607","article-title":"Antioxidants and atherosclerotic heart disease","volume":"337","author":"Diaz","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet."},{"key":"10.1194\/jlr.M200439-JLR200_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199404143301501","article-title":"The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers","volume":"330","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM199605023341801","article-title":"Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease","volume":"334","author":"Hennekens","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(96)90866-1","article-title":"Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)","volume":"347","author":"Stephens","year":"1996","journal-title":"Lancet."},{"key":"10.1194\/jlr.M200439-JLR200_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","article-title":"MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet."},{"key":"10.1194\/jlr.M200439-JLR200_bib23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/hq0801.095151","article-title":"Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL","volume":"21","author":"Cheung","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M200439-JLR200_bib25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0735-1097(00)00527-1","article-title":"Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women","volume":"35","author":"Rajaratnam","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.M200439-JLR200_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11745-000-0616-9","article-title":"Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women","volume":"35","author":"Matthan","year":"2000","journal-title":"Lipids."},{"key":"10.1194\/jlr.M200439-JLR200_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ajcn\/43.1.92","article-title":"Serum plant sterols and their relation to cholesterol absorption","volume":"43","author":"Tilvis","year":"1986","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.M200439-JLR200_bib28","series-title":"Manual of Laboratory Operations: Lipids Research Clinics Program","first-page":"1","article-title":"Lipid and lipoprotein analysis","year":"1982"},{"key":"10.1194\/jlr.M200439-JLR200_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","article-title":"Enzymatic methods for quantification of lipoprotein lipids","volume":"129","author":"Warnick","year":"1986","journal-title":"Methods Enzymol."},{"key":"10.1194\/jlr.M200439-JLR200_bib30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.M200439-JLR200_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM199007263230403","article-title":"Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol","volume":"323","author":"Reihner","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M200439-JLR200_bib32","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.ATV.20.5.1340","article-title":"Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol","volume":"20","author":"Miettinen","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M200439-JLR200_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0026-0495(92)90050-K","article-title":"Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man","volume":"41","author":"Vanhanen","year":"1992","journal-title":"Metabolism."},{"key":"10.1194\/jlr.M200439-JLR200_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.ATV.12.7.807","article-title":"Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum","volume":"12","author":"Uusitupa","year":"1992","journal-title":"Arterioscler. Throm."},{"key":"10.1194\/jlr.M200439-JLR200_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.aje.a115479","article-title":"Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population","volume":"131","author":"Miettinen","year":"1990","journal-title":"Am. J. Epidemiol."},{"key":"10.1194\/jlr.M200439-JLR200_bib36","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1172\/JCI106315","article-title":"Metabolism of beta-sitosterol in man","volume":"49","author":"Salen","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M200439-JLR200_bib37","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1080\/096374800111118","article-title":"Effects of administration of alpha-tocopherol and tocotrienols on serum lipids and liver HMG-CoA reductase activity","volume":"51","author":"Knor","year":"2000","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1194\/jlr.M200439-JLR200_bib38","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1016\/S0021-9258(18)82115-9","article-title":"Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase","volume":"268","author":"Parker","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M200439-JLR200_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002280100329","article-title":"Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins)","volume":"57","author":"Igel","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1194\/jlr.M200439-JLR200_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","article-title":"Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation","volume":"20","author":"Wagner","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl","key":"10.1194\/jlr.M200439-JLR200_bib41","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0021-9150(97)00319-5","article-title":"Direct vascular effects of HMG-CoA reductase inhibitors","volume":"137","author":"Bellosta","year":"1998","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M200439-JLR200_bib42","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/01.ATV.0000034706.24149.95","article-title":"Antioxidant vitamins and lipid therapy: end of a long romance?","volume":"22","author":"Brown","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520311706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520311706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M200439-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T15:39:44Z","timestamp":1637422784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520311706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0022227520311706"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m200439-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}